BDTX vs MTCH · $95.7M cap vs P/E 13, rev $3.48B
Black Diamond Therapeutics Inc (BDTX) versus Match Group Inc (MTCH) — a side-by-side from cached financials, not a winner call.
Black Diamond Therapeutics Inc (BDTX) is a biotechnology company listed on NASDAQ.
Match Group Inc (MTCH) is a internet content & information company listed on NASDAQ.
BDTX does not have a complete income-statement cache yet.
Latest reported MTCH revenue for 2024-12-31 was $3.48B. Net income was $551.3M. Revenue was up 3.4% from 2023-12-31 to 2024-12-31. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
BDTX currently screens at market cap $95.7M. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
Not investment advice. Open the BDTX and MTCH stock pages for the full models.
Not investment advice.